In fact, many studies have reported findings related to the association between CLU expression and cancer incidence and progression, such as in lung cancer, prostate cancer, colon cancer, and hepatocellular carcinoma [13,58,59,60]. This evidence concerns the gene CLU and prostate carcinoma.